HANALL BIOPHARMA
HanAll Biopharma is Worldโs Best Bio Pharma for R&D of New Innovative Medicine Respectful Pharmaceutical Company to Contribute to Health of the World and to Lead Health Improvement of Mankind.
HANALL BIOPHARMA
Social Links:
Industry:
Biotechnology Fitness
Status:
Active
Contact:
306-81-05479
Email Addresses:
[email protected]
Technology used in webpage:
Apache Apache 2.4 Java EE OpenSSL GeoTrust SSL RapidSSL Unix OpenSSL 1.0.1 Apache Tomcat JK LG U Plus
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Bharat Serums and Vaccines
Bharat Serums and Vaccines develops biopharmaceutical products for patient health improvement.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Current Employees Featured
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-04-11 | Turn.bio | HanAll Biopharma investment in Venture Round - Turn.bio | N/A |
2021-08-19 | Alloplex Biotherapeutics | HanAll Biopharma investment in Corporate Round - Alloplex Biotherapeutics | 1000 K USD |
Key Employee Changes
Date | New article |
---|---|
2022-02-21 | HanAll Biopharma Appoints Almira Chabi as Chief Medical Officer and Chief Development Officer |
More informations about "HanAll Biopharma"
ABOUT US - HANALL
HanAll Biopharma disclaims all express or implied warranties, including warranties of merchantability and fitness for a particular purpose. Neither HanAll Biopharma nor any parties involved in creating, producing, or delivering this โฆSee details»
ABOUT US | HANALL
At HanAll Biopharma, our impact spans the globe with a dynamic and extensive network of research and development teams located in four different countries - Korea, the United States, Indonesia, and Japan. This global scale and reach โฆSee details»
HANALL BIOPHARMA Co., Ltd. - Drug pipelines, Patents ... - Patsnap
May 1, 2023 About HanAll Biopharma HanAll Biopharma (KRX: 009420.KS) is a global biopharmaceutical company with presence in Korea, the USA, Japan, and Indonesia with the โฆSee details»
NEWS ROOM | HANALL
Both CEOs will collaborate in building the organization and business development to drive HanAllโs next phase of growth in both domestic and global markets. ... About HanAll โฆSee details»
HanAll Biopharma - Crunchbase Investor Profile
Contact Email [email protected] Phone Number 306-81-05479 HanAll Biopharma is Worldโs Best Bio Pharma for R&D of New Innovative Medicine Respectful Pharmaceutical Company to Contribute to Health of the World and โฆSee details»
HanAll Biopharma Assigns Su-jin Park as Co-CEO to Drive Next
Mar 29, 2023 Sean Jeong, who has served as a Co-CEO of HanAll Biopharma since March 2021, will continue to lead HanAllโs R&D vision and strategy alongside Mr. Park, who will focus โฆSee details»
HanAll BioPharma Company Profile - Office Locations ... - Craft
Oct 29, 2024 HanAll BioPharma has 5 employees across 4 locations and โฉ134.91 b in annual revenue in FY 2023. See insights on HanAll BioPharma including office locations, competitors, โฆSee details»
HanAll Biopharma Co Ltd: Overview - GlobalData
HanAll Biopharma Co Ltd (HanAll), formerly HanAll Pharmaceutical Co Ltd, is a developer of generic and specialty drugs for treatment of diseases related to digestive, endocrine, โฆSee details»
HanAll Biopharma Co. Ltd. - BioCentury Company Profiles - BCIQ
Jul 15, 2024 HanAll Biopharma Co. Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
NEWS ROOM - HANALL
About HanAll Biopharma. HanAll Biopharma (KRX: 009420.KS) is a global biopharmaceutical company with presence in Korea, the USA, Japan, and Indonesia with a mission of making โฆSee details»
BQURA | Companies - Hanall Biopharma
Dec 6, 2024 HanAll Biopharma has established itself as a leader in innovative drug development, leveraging its global clinical development capabilities and antibody research โฆSee details»
HanAll Biopharma Co - Company Profile - GlobalData
HanAll Biopharma Co Ltd (HanAll), formerly HanAll Pharmaceutical Co Ltd, is a developer of generic and specialty drugs for the treatment of diseases related to digestive, endocrine, โฆSee details»
HanAll Biopharma - Products, Competitors, Financials, Employees ...
HanAll Biopharma is a biopharmaceutical company focused on the research and development of innovative drugs. The company's main offerings include the development of treatments for โฆSee details»
Hanall Biopharma - Overview, News & Similar companies
Oct 26, 2023 Who is Hanall Biopharma. HanAll Biopharma (KRX: 009420.KS) is a global biopharmaceutical company founded in 1973 with a mission of making meaningful โฆSee details»
Turn Bio and HanAll to develop therapies for age-related conditions
May 29, 2024 HanAll Biopharma CEO Sean Jeong stated: โTurn Bioโs innovative approach to epigenetic reprogramming aligns closely with HanAllโs mission to explore innovative medicines โฆSee details»
HanAll Biopharma - Contacts, Employees, Board Members
HanAll Biopharma has 3 current employee profiles, including CEO & President Seung Kook Park. Contacts. Edit Contacts Section. Job Department. Protected Content. Operations. Director โฆSee details»
NEWS ROOM | HANALL
Apr 30, 2024 About HanAll Biopharma. HanAll Biopharma (KRX: 009420.KS) is a global biopharmaceutical company with a presence in Korea, the USA, Japan, and Indonesia with a โฆSee details»
NEWS ROOM - HANALL
HanAll Biopharma Reports Second Quarter 2023 Financial Results and Provides a Business Update 2023.07.28 l Sales recorded KRW 41.4 billion, a 58 percent increase from the same โฆSee details»
HanAll Biopharma sees highest patent filings and grants during โฆ
Feb 27, 2024 HanAll Biopharma saw the highest growth of 299% in patent filings in December and 99% in grants in October in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in โฆSee details»